Sichuan Huiyang Life Science and Technology Corporation
4 clinical trials · Sponsor
◉ Watch Sichuan Huiyang Life Science and Technology Corporation
| Record | Firm | Date |
|---|---|---|
| rSIFN-co in Combination With Total Neo-adjuvant Therapy in Subjects With Mid-low Locally Advanced Rectal Cancer (NCT07662278) | Sichuan Huiyang Life Science and Technology Corporation | 2027-01-01 |
| rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19 (NCT05485584) | Sichuan Huiyang Life Science and Technology Corporation | 2022-07-01 |
| Study of rSIFN-co for Patients With Advanced Solid Tumors (NCT02464007) | Sichuan Huiyang Life Science and Technology Corporation | 2016-01-01 |
| A Study of rSIFN-co in Subjects With Advanced Solid Tumors (NCT02387307) | Sichuan Huiyang Life Science and Technology Corporation | 2013-07-01 |
Track Sichuan Huiyang Life Science and Technology Corporation automatically
Every clearance here is in the API, with alerts when new ones post.